Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruihao Huang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Chinese Medical Journal|December 12, 2025
Recipient-derived vs. donor-derived CAR-T-cell therapy in relapsed B-cell acute lymphoblastic leukemia patients after transplantation: A multi-center retropective studyLichao Liu, Yongxian Hu, Ruihao Huang, et al.
Experimental Hematology & Oncology|January 3, 2025
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trialRuihao Huang, Xiaoqi Wang, Hongju Yan, et al.
JAMA Oncology|December 28, 2023
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical TrialRuihao Huang, Ting Chen, Sanbin Wang, et al.
Clinical Pharmacology and Therapeutics|February 13, 2024
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use AuthorizationQi Liu, Raj Nair, Ruihao Huang, et al.
Cancers|June 24, 2022
The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient SurvivalXin Li, Xiaoqi Wang, Ruihao Huang, et al.
Cancer Research Communications|March 2, 2023
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial DataQi Liu, Chenan Zhang, Yue Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2025
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical TrialHan Yao, Ruihao Huang, Haixia Fu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 17, 2025
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangementYi Xu, Shengwen Calvin Li, Jeffrey Xiao, et al.
Clinical Pharmacology and Therapeutics|November 15, 2023
Methodology for Good Machine Learning with Multi-Omics DataThibaud Coroller, Berkman Sahiner, Anup Amatya, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Chinese Medical Journal|December 12, 2025
Recipient-derived vs. donor-derived CAR-T-cell therapy in relapsed B-cell acute lymphoblastic leukemia patients after transplantation: A multi-center retropective studyLichao Liu, Yongxian Hu, Ruihao Huang, et al.
Experimental Hematology & Oncology|January 3, 2025
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trialRuihao Huang, Xiaoqi Wang, Hongju Yan, et al.
JAMA Oncology|December 28, 2023
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical TrialRuihao Huang, Ting Chen, Sanbin Wang, et al.
Clinical Pharmacology and Therapeutics|February 13, 2024
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use AuthorizationQi Liu, Raj Nair, Ruihao Huang, et al.
Cancers|June 24, 2022
The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient SurvivalXin Li, Xiaoqi Wang, Ruihao Huang, et al.
Cancer Research Communications|March 2, 2023
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial DataQi Liu, Chenan Zhang, Yue Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2025
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical TrialHan Yao, Ruihao Huang, Haixia Fu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 17, 2025
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangementYi Xu, Shengwen Calvin Li, Jeffrey Xiao, et al.
Clinical Pharmacology and Therapeutics|November 15, 2023
Methodology for Good Machine Learning with Multi-Omics DataThibaud Coroller, Berkman Sahiner, Anup Amatya, et al.
Pageof 4